Consistently, peripheral administration of human recombinant apoJ/clusterin in APP23 mice, induced a reduction of insoluble Aβ and cerebral amyloid angiopathy in the brain [118]. The gene discussed is CLU; the disease is cerebral amyloid angiopathy.